Stockscreener 앱 받기
4.85
2.32%
0.11
시장 영업 전:
4.85
전일 마감가:
$4.74
열려 있는:
$4.78
하루 거래량:
391.96K
Relative Volume:
1.41
시가총액:
$127.61M
수익:
$47.26M
순이익/손실:
$-58.48M
주가수익비율:
-1.793
EPS:
-2.7049
순현금흐름:
$-40.45M
1주 성능:
-20.23%
1개월 성능:
-6.91%
6개월 성능:
-29.40%
1년 성능:
-67.62%
1일 변동 폭
$4.43
$4.939
1주일 범위
$4.3701
$6.22
52주 변동 폭
$4.2993
$15.00
Cvrx Inc Stock (CVRX) Company Profile
명칭
Cvrx Inc
전화
(763) 416-2850
주소
9201 WEST BROADWAY AVENUE, MINNEAPOLIS
Compare CVRX vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CVRX
Cvrx Inc
|
4.85 | 124.72M | 47.26M | -58.48M | -40.45M | -2.7049 |
|
ABT
Abbott Laboratories
|
113.29 | 195.21B | 44.33B | 6.48B | 6.92B | 3.7033 |
|
SYK
Stryker Corp
|
377.32 | 141.28B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
98.49 | 123.60B | 35.48B | 4.64B | 5.41B | 3.5856 |
|
BSX
Boston Scientific Corp
|
76.28 | 113.14B | 20.08B | 2.89B | 3.82B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
78.98 | 45.52B | 6.07B | 1.06B | 799.60M | 1.8527 |
Cvrx Inc Stock (CVRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-05-09 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2025-01-14 | 업그레이드 | William Blair | Mkt Perform → Outperform |
| 2024-09-10 | 개시 | Cantor Fitzgerald | Overweight |
| 2024-07-11 | 재확인 | Lake Street | Buy |
| 2024-05-01 | 재개 | Craig Hallum | Buy |
| 2024-05-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-05-01 | 다운그레이드 | William Blair | Outperform → Mkt Perform |
| 2023-01-31 | 개시 | Lake Street | Buy |
| 2022-07-18 | 개시 | Craig Hallum | Buy |
| 2021-07-26 | 개시 | Canaccord Genuity | Buy |
| 2021-07-26 | 개시 | Piper Sandler | Overweight |
| 2021-07-26 | 개시 | William Blair | Outperform |
모두보기
Cvrx Inc 주식(CVRX)의 최신 뉴스
Cantor Fitzgerald Upgrades CVRx (NASDAQ:CVRX) to Strong-Buy - MarketBeat
Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc.CVRX - marketscreener.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Beta Bionics, Inc. - GlobeNewswire Inc.
Short Interest in CVRx, Inc. (NASDAQ:CVRX) Increases By 23.4% - MarketBeat
Why CVRx Inc. stock remains on buy listsAnalyst Downgrade & Long Hold Capital Preservation Plans - mfd.ru
CVRx Inc (CVRX) Q4 2025 Earnings Call Highlights: Revenue Growth and Strategic Expansions Amid ... By GuruFocus - Investing.com Canada
Analysts Are Updating Their CVRx, Inc. (NASDAQ:CVRX) Estimates After Its Full-Year Results - Yahoo Finance
Piper Sandler Maintains CVRx Inc(CVRX.US) With Buy Rating, Maintains Target Price $12 - 富途牛牛
CCORF Maintains CVRx Inc(CVRX.US) With Buy Rating, Cuts Target Price to $10 - 富途牛牛
Why CVRx Inc. stock is favored by top institutionsJuly 2025 Recap & Expert Approved Trade Ideas - mfd.ru
CVRx Earnings Call: Investing Heavily for Future Growth - The Globe and Mail
Canaccord Genuity lowers CVRx stock price target to $10 on sector multiple decline By Investing.com - Investing.com Australia
Canaccord Genuity lowers CVRx stock price target to $10 on sector multiple decline - Investing.com Nigeria
CVRx, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
CVRx, Inc. SEC 10-K Report - TradingView
CVRx revenue up 4% to USD 16M in Q4 2025 - Medical Buyer
CVRx (CVRX) Q3 Loss Near US$12.9 Million Reinforces Profitability Concerns Despite Growth Narratives - Sahm
CVRx Q4 2025 Earnings Call Transcript - MarketBeat
CVRx Q4 2025 Earnings Call Insights - Intellectia AI
CVRx Reports Fourth Quarter and Full Year 2025 Financial and Operating Results - The Globe and Mail
Responsive Playbooks and the CVRX Inflection - Stock Traders Daily
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc.CVRX - PR Newswire
CVRx (CVRX) Q4 2025 Earnings Call Transcript - AOL.com
CVRx Q4 Earnings Call Highlights - MarketBeat
CVRX: Revenue and margin growth set the stage for accelerated expansion with new reimbursement and clinical trial catalysts - TradingView
CVRx earnings missed by $0.02, revenue topped estimates - Investing.com Canada
CVRx (CVRX) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Earnings call transcript: CVRx Q4 2025 sees stock surge despite earnings miss - Investing.com
CVRx (NASDAQ:CVRX) Announces Earnings Results, Misses Expectations By $0.04 EPS - MarketBeat
CVRx: Q4 Earnings Snapshot - kare11.com
CVRx: Fourth Quarter Financial Highlights - Bitget
What’s the beta of CVRx Inc. stockOil Prices & Weekly Setup with High ROI Potential - mfd.ru
Can CVRx Inc. stock deliver consistent earnings growthJuly 2025 News Drivers & AI Enhanced Trade Execution Alerts - mfd.ru
Will CVRX benefit from government policyJuly 2025 News Drivers & Fast Moving Stock Watchlists - mfd.ru
CVRx's Earnings: A Preview - Benzinga
Can CVRx Inc. expand into new markets2025 Growth vs Value & AI Driven Stock Reports - mfd.ru
CVRX INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving CVRx Inc. - Business Wire
Does CVRx Inc. meet Warren Buffett’s criteria2025 Valuation Update & Long Hold Capital Preservation Plans - mfd.ru
CVRX Stock Price and Chart — NASDAQ:CVRX - TradingView
CVRx, Inc. (NASDAQ:CVRX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
CVRx showcases Barostim integration at heart failure program - Traders Union
Growth Value: Should you buy the dip on CVRx IncJuly 2025 Retail & Safe Investment Capital Preservation Plans - baoquankhu1.vn
Returns Recap: Whats the beta of CVRx Inc stockJuly 2025 Review & Free Technical Confirmation Trade Alerts - baoquankhu1.vn
S P Trends: Whats the beta of CVRx Inc stockJuly 2025 Retail & Daily Profit Maximizing Tips - baoquankhu1.vn
Income Plays: How correlated is CVRX to the S P5002025 Trading Recap & Verified Entry Point Signals - baoquankhu1.vn
Understanding the Setup: (CVRX) and Scalable Risk - Stock Traders Daily
CVRx ALERT: Bragar Eagel & Squire, P.C. is Investigating - GlobeNewswire
CVRx ALERT: Bragar Eagel & Squire, P.C. is Investigating CVRx Inc. on Behalf of CVRx Stockholders and Encourages Investors to Contact the Firm - GlobeNewswire Inc.
CVRx to Report Fourth Quarter 2025 Financial and Operating Results and Host Conference Call on February 12, 2026 - Sahm
CVRx INC. INVESTOR ALERT: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud - Business Wire
Cvrx Inc (CVRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.13%
자본화:
|
볼륨(24시간):